177 related articles for article (PubMed ID: 23544173)
1. FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In Vivo.
Gillory LA; Stewart JE; Megison ML; Nabers HC; Mroczek-Musulman E; Beierle EA
Transl Oncol; 2013 Apr; 6(2):206-15. PubMed ID: 23544173
[TBL] [Abstract][Full Text] [Related]
2. Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells.
Waters AM; Stafman LL; Garner EF; Mruthyunjayappa S; Stewart JE; Mroczek-Musulman E; Beierle EA
Transl Oncol; 2016 Aug; 9(4):263-73. PubMed ID: 27567948
[TBL] [Abstract][Full Text] [Related]
3. FAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumors.
Megison ML; Gillory LA; Stewart JE; Nabers HC; Mrozcek-Musulman E; Beierle EA
Mol Cancer Res; 2014 Apr; 12(4):514-26. PubMed ID: 24464916
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma.
Stewart JE; Ma X; Megison M; Nabers H; Cance WG; Kurenova EV; Beierle EA
Mol Carcinog; 2015 Jan; 54(1):9-23. PubMed ID: 23868727
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cell migration by focal adhesion kinase: Time-dependent difference in integrin-induced signaling between endothelial and hepatoblastoma cells.
Yu H; Gao M; Ma Y; Wang L; Shen Y; Liu X
Int J Mol Med; 2018 May; 41(5):2573-2588. PubMed ID: 29484384
[TBL] [Abstract][Full Text] [Related]
6. FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.
Megison ML; Stewart JE; Nabers HC; Gillory LA; Beierle EA
Clin Exp Metastasis; 2013 Jun; 30(5):555-68. PubMed ID: 23208732
[TBL] [Abstract][Full Text] [Related]
7. The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor.
Aye JM; Stafman LL; Williams AP; Garner EF; Stewart JE; Anderson JC; Mruthyunjayappa S; Waldrop MG; Goolsby CD; Markert HR; Quinn C; Marayati R; Mroczek-Musulman E; Willey CD; Yoon KJ; Whelan KF; Beierle EA
Oncotarget; 2019 Sep; 10(53):5534-5548. PubMed ID: 31565187
[TBL] [Abstract][Full Text] [Related]
8. Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival.
Gillory LA; Stewart JE; Megison ML; Waters AM; Beierle EA
J Surg Res; 2015 Jun; 196(2):339-49. PubMed ID: 25862488
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.
Beierle EA; Ma X; Stewart J; Nyberg C; Trujillo A; Cance WG; Golubovskaya VM
Cell Cycle; 2010 Mar; 9(5):1005-15. PubMed ID: 20160475
[TBL] [Abstract][Full Text] [Related]
10. High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcoma.
Crompton BD; Carlton AL; Thorner AR; Christie AL; Du J; Calicchio ML; Rivera MN; Fleming MD; Kohl NE; Kung AL; Stegmaier K
Cancer Res; 2013 May; 73(9):2873-83. PubMed ID: 23536552
[TBL] [Abstract][Full Text] [Related]
11. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
Liu L; Yang X; Li NF; Lin L; Luo H
Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
[No Abstract] [Full Text] [Related]
12. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
[TBL] [Abstract][Full Text] [Related]
13. [RNA interference targeting focal adhesion kinase inhibited the growth of human hepatocellular carcinoma sk-hep-1].
Xu WJ; Zhang S; Zhang N; Yang Y; Wei YQ; Deng HX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):455-60. PubMed ID: 21866625
[TBL] [Abstract][Full Text] [Related]
14. The direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis.
Golubovskaya VM; Zheng M; Zhang L; Li JL; Cance WG
BMC Cancer; 2009 Aug; 9():280. PubMed ID: 19671193
[TBL] [Abstract][Full Text] [Related]
15. Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.
Stafman LL; Mruthyunjayappa S; Waters AM; Garner EF; Aye JM; Stewart JE; Yoon KJ; Whelan K; Mroczek-Musulman E; Beierle EA
Oncotarget; 2018 Apr; 9(32):22665-22679. PubMed ID: 29854306
[TBL] [Abstract][Full Text] [Related]
16. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
[TBL] [Abstract][Full Text] [Related]
17. A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [3.3.1.1(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo.
Golubovskaya VM; Figel S; Ho BT; Johnson CP; Yemma M; Huang G; Zheng M; Nyberg C; Magis A; Ostrov DA; Gelman IH; Cance WG
Carcinogenesis; 2012 May; 33(5):1004-13. PubMed ID: 22402131
[TBL] [Abstract][Full Text] [Related]
18. FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro.
Mohamed AA; Thomsen A; Follo M; Zamboglou C; Bronsert P; Mostafa H; Amen A; Mekawy M; Grosu AL; Brunner TB
Strahlenther Onkol; 2021 Jan; 197(1):27-38. PubMed ID: 32705304
[TBL] [Abstract][Full Text] [Related]
19. Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models.
Walsh C; Tanjoni I; Uryu S; Tomar A; Nam JO; Luo H; Phillips A; Patel N; Kwok C; McMahon G; Stupack DG; Schlaepfer DD
Cancer Biol Ther; 2010 May; 9(10):778-90. PubMed ID: 20234193
[TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis.
Kornberg LJ
Head Neck; 1998 Dec; 20(8):745-52. PubMed ID: 9790298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
